Skip to main content
. 2018 Oct 1;4(1):e000409. doi: 10.1136/bmjsem-2018-000409

Table 1.

Methodological qualities of included studies: PEDro

Trial Specified eligibility criteria Random allocation Concealed allocation Similarity at baseline on key measures Subject blinding Therapist blinding Assessor blinding >85% follow-up of at least one key outcome Intention-to treat analysis Between-group statistical comparison for at least one key outcome Point estimates and measures of variability provided for at least one key outcome Total
Asthma
Ahmaidi et al (1993)28 x X NA NA X X X 4
Andrade et al (2014)29 NA NA X X 7
Basaran et al (2006)30 X X NA NA X X 5
Chang et al (2008)32 X X NA NA X X X 4
Counil et al (2003)33 X NA NA X 7
Edenbrandt et al (1990)35 X X NA NA X 6
Fanelli et al (2007)36 NA NA 9
Latorre-Román et al (2014)40 X NA NA X X 6
Matsumoto et al (1999)41 X X NA NA X 6
Moreira et al (2008)42 NA NA X 8
Onur et al (2011)43 X NA NA X 7
Silva et al (2006)49 X NA NA X 7
Silva et al. (2013)50 X X NA NA X X 5
Van Veldhoven et al. (2001)51 X NA NA X X 6
Wang et al (2009)52 X X NA NA X 6
Weisgerber et al (2003)53 X NA NA X X X 5
Wicher et al (2010)54 X NA NA X X X 5
Cystic fibrosis
Cerny et al (1989)31 X X X NA NA X 5
De Oliveira et al (2009)34 X NA NA X X X 5
Hebestreit et al (2010)37 X NA NA X X 6
Hommerding et al (2015)38 X NA NA X 7
Klijn et al (2004)39 NA NA X 8
Santana Sosa et al (2012)44 X NA NA 8
Santana Sosa et al (2014) X NA NA 8
Schindel et al (2015)46 X NA NA 8
Schneiderman-Walker et al (2000)47 X X NA NA X X 5
Selvadurai et al (2002)48 NA NA X 8